Related Experiment Video

Updated: Aug 23, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

[Antibiotic treatment of bacterial meningitis]

Jean-Paul Stahl1

  • 1Service d'infectiologie, CHU de Grenoble, BP 217, 38043, Grenoble Cedex 09. JPStahl@chu-grenoble.fr

La Revue Du Praticien
|August 7, 2004
PubMed

Insights

Community-acquired bacterial meningitis, often caused by drug-resistant Streptococcus pneumoniae and Neisseria meningitidis, requires careful antibiotic selection. Adjunctive non-antibiotic treatments are also proving beneficial.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Context:

  • Bacterial meningitis is a significant global health concern.
  • Key pathogens include Streptococcus pneumoniae and Neisseria meningitidis.
  • Increasing antibiotic resistance poses a therapeutic challenge.

Purpose:

  • To review current treatment strategies for community-acquired bacterial meningitis.
  • To highlight the growing issue of antibiotic resistance in key meningitis pathogens.
  • To discuss the role of adjunctive therapies.

Summary:

  • Community-acquired bacterial meningitis is primarily caused by Streptococcus pneumoniae and Neisseria meningitidis.
  • Antibiotic resistance, particularly in S. pneumoniae, is a growing problem in countries like France.
  • Current empirical treatment involves third-generation cephalosporins, with vancomycin added for penicillin-resistant strains.
  • Non-antibiotic drugs are validated as effective adjunctive treatments.

Impact:

  • Informs clinical decision-making for empirical meningitis treatment.
  • Underscores the need for antimicrobial stewardship and surveillance.
  • Highlights the importance of adjunctive therapies in improving patient outcomes.

More Related Videos

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...